
Summary for Tradename: diovan
|
|
Latest news for DIOVANSwiss Stocks Retreat; Roche Shares Decline as UBS, Credit Suisse Advance26 July 2010, 9:59 am 3 Buys Suffering From the Health-Care Hangover23 July 2010, 2:26 pm Press Release23 July 2010, 9:18 am Swiss Stocks Decline as Syngenta, Roche Fall; ABB Shares Rise in Zurich23 July 2010, 6:59 am Georg Fischer, Kuehne & Nagel International, Novartis: Swiss Stock Preview18 July 2010, 5:14 am A Positive Sign for Pharma Earnings Season16 July 2010, 4:14 pm Zacks Analyst Blog Highlights: Novartis AG, Altria, Goodyear, Halliburton and Schlumberger16 July 2010, 10:59 am U.S. Probing Cancer Risk of Blood Pressure Drugs16 July 2010, 8:36 am FDA Probing Possible Cancer Link to Popular Blood Pressure Drugs15 July 2010, 3:51 pm Courtesy of Yahoo News |
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | DIOVAN | valsartan | 020665 | Dec 23, 1996 | DISCN | No | 5,399,578*PED | Y | Sep 21, 2012 | |||
| Novartis | DIOVAN | valsartan | 021283 | Aug 14, 2002 | RX | No | May 29, 2011 | |||||
| Novartis | DIOVAN | valsartan | 021283 | Aug 14, 2002 | RX | No | Nov 29, 2010 |
| Drugname | Dosage | Strength | RLD | Submissiondate |
| valsartan and hydrochlorothiazide | Tablets | 320 mg/12.5 mg and 320 mg/25 mg | Diovan HCT | 2/7/2007 |
| valsartan and hydrochlorothiazide | Tablets | 80 mg/12.5 mg, 160 mg/12.5 mg and 160 mg/25 mg | Diovan HCT | 12/2/2005 |
| valsartan | Tablets | 40 mg, 80 mg,160 mg | Diovan | 12/28/2004 |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.